Status:
COMPLETED
Comparison Across Treatment Conditions to Reduce Smokeless Tobacco Use
Lead Sponsor:
University of Minnesota
Conditions:
Tobacco Use Disorder
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
Smokeless tobacco (ST), which includes both chewing tobacco and snuff, has health risks associated with its use. While treatment programs that focus on stopping tobacco use may be effective, past rese...
Detailed Description
Individuals who use ST are at increased risk for cancer or dying from cardiovascular disease. Other long-term effects include tooth abrasion, gum recession, and loss of bone in the jaw. Many individua...
Eligibility Criteria
Inclusion
- No interest in stopping ST use within 90 days of study entry
- Daily use of ST in the 6 months prior to study entry
Exclusion
- Current use of tobacco or nicotine products, other than ST
- Current unstable medical and mental health conditions
- Use of any medication that may affect tobacco use or be affected by a reduction in tobacco use
- Pregnant or breastfeeding
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
332 Patients enrolled
Trial Details
Trial ID
NCT00218296
Start Date
November 1 2006
End Date
January 1 2009
Last Update
October 16 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Univerisity of Minnesota
Minneapolis, Minnesota, United States, 55414